IEX logo

IDEX Corporation

IEX · What the business does, what can go wrong, and how options sellers approach it

What it does

IDEX Corporation makes specialized engineered products that move, measure and control fluids and other materials. Its range includes pumps, flow meters, valves, dispensing systems and related components. These are usually built into customers' equipment or processes.

The business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. Customers span industrial, water, life science, and fire and safety markets, among others.

How it makes money

IDEX sells components and systems to manufacturers and operators, often tailored to a specific application. Many products are small parts of larger machines but critical to their performance, which can support pricing power.

Replacement parts, service and repeat orders add recurring demand. The company has also grown by acquiring niche manufacturers.

Why investors own it

  • Focus on niche markets where performance and reliability matter more than lowest price.
  • Exposure to varied end markets, which can soften the impact when one is weak.
  • A long record of buying and integrating specialty businesses.
  • A dividend, often seen as a sign of steady cash generation, though dividends are never guaranteed.

What can go wrong

Industrial demand moves with the economic cycle. When customers cut capital spending, orders for pumps and flow equipment can slow quickly.

Acquisitions may not deliver expected results or may prove overpriced. Currency swings, tariffs and supply chain disruptions can pressure margins, since the company makes and sells products in many countries. Some segments, such as life science, can see uneven demand as customer inventories rise and fall.

What to watch

  • Organic sales growth (excluding acquisitions and currency)
  • Order trends and backlog
  • Operating margin by segment
  • Free cash flow conversion
  • Acquisition activity and integration
  • Industrial, life science and water demand

Options income angle

Options on IEX trade across multiple expirations, but volume is usually lighter than in widely traded stocks, so bid-ask spreads can be wide.

Implied volatility tends to rise before quarterly earnings and during industrial or market worries, then often eases after results.

One caution for premium sellers: earnings reactions can gap the price sharply, leaving a covered call writer with capped upside after a jump, or a short put seller owning shares after a drop. Check the earnings date before choosing an expiration.

What the latest 10-K says

A plain-English read of the Risk Factors and Management's Discussion in the 10-K for the year ended December 31, 2025, filed February 19, 2026. Figures are as the filing reports them. Read the filing on SEC.gov

The filing in brief

IDEX reported record net sales of $3,457.5 million for 2025, but most of the 6% growth came from the Mott acquisition rather than from the existing businesses. Diluted earnings per share fell to $6.41 as interest, tax and amortization costs rose. Management points to data center, semiconductor and water demand as bright spots, while core industrial markets remain soft.

How the business did

  • Net sales rose 6%, but organic sales (which strip out acquisitions, divestitures and currency effects) rose only 1%. Price increases in every segment more than offset lower volumes in the Fluid & Metering (FMT) and Fire & Safety/Diversified Products (FSDP) segments.
  • Diluted EPS attributable to IDEX was $6.41, down 3%. Adjusted diluted EPS, a non-GAAP measure that removes items management considers unrelated to ongoing operations, was $7.95, up 1%. Interest expense - net rose to $64.4 million from $44.5 million because of debt taken on to buy Mott. The effective tax rate rose to 23.7% from 21.1%.
  • Health & Science Technologies (HST) net sales rose 15%, with organic growth of 4% from data center, semiconductor consumables and space and defense. FMT net sales fell 1%, and FSDP net sales were flat. FSDP was hurt by lower volumes in Dispensing and in Fire & Safety in Asia.
  • Operating cash flow was $680.4 million and free cash flow (operating cash flow minus capital spending) was $616.8 million. The company paid $248 million in share repurchases and $213 million in dividends.
  • Restructuring expenses and asset impairments rose to $20.7 million, mostly severance from organizational changes.

Risks specific to this company

  • Acquisition-built balance sheet: Goodwill and intangible assets totaled $3,414.5 million and $1,247.4 million. A shortfall in a business unit's performance could force a non-cash write-off that reduces profit and net worth.
  • Reliance on acquisitions: Growth depends partly on buying and integrating companies, which can bring unexpected liabilities and more debt. Past deals have already added borrowing.
  • Geographic and currency exposure: In 2025, 51% of sales came from U.S. customers and 49% from outside the U.S. About 34% of net sales were recorded by subsidiaries whose functional currency is not the U.S. Dollar, so a stronger dollar can reduce reported results.
  • Uncertain AI-related demand: Demand for data center power and semiconductor projects has grown, but the filing says the industry's development is difficult to predict, and swings can change the timing of customer orders.
  • Commodity-linked customers: A sustained decline in oil and other commodity prices can lead customers to delay or cancel orders, leaving factories underused.
  • Supply and trade costs: The company buys substantial raw materials and components, and new or higher tariffs and supplier disruptions could change availability and cost.

What management is watching

  • For 2026, management plans to advance its 8020 operating framework and make disciplined bolt-on acquisitions, alongside returning capital to shareholders.
  • HST is expected to keep growing on data center, semiconductor, space and defense, food and beverage and pharmaceutical demand. Industrial and automotive businesses have yet to see a meaningful recovery.
  • FMT should see continued momentum in Water, while core industrial markets track flat and chemical, energy and agricultural demand is softening. FSDP faces near-term headwinds from weak Fire & Safety markets outside the United States and subdued Dispensing capital spending.
  • On capital, the board authorized an additional $635.0 million of share repurchases in September 2025, leaving $924.7 million of authorization at year end. The leverage ratio was 1.96 to 1 against a covenant maximum of 3.50 to 1.
  • Management points investors to organic sales, Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization, adjusted for certain items), free cash flow and free cash flow conversion.

What the latest 10-Q says

A plain-English read of Management's Discussion (and any new or changed risk factors) in the 10-Q for the quarter ended September 30, 2026, filed October 28, 2026. Figures are as the filing reports them. Read the filing on SEC.gov

The quarter in brief

IDEX reported third-quarter net sales of $951.7 million, up 8% on both a reported and an organic basis (organic strips out acquisitions and currency swings). Diluted earnings per share of $1.95 rose 15%. Growth was led by the Health & Science Technologies (HST) segment, helped by AI-driven demand for data center power and semiconductors, while the other two segments grew more slowly.

How the business did

  • Quarter and year to date: Operating income was $208.0 million, up 12%, and gross margin was 45.1% versus 44.5% a year earlier. For the nine months, net sales were $2,759.2 million, up 8%, and diluted EPS was $5.49, up 17%.
  • Segments: HST net sales were $433.5 million, up 14%, with an Adjusted EBITDA margin of 28.8%. Fluid & Metering Technologies (FMT) had net sales of $327.9 million, up 3%, with lower volumes in chemical, energy and agriculture markets. Fire & Safety/Diversified Products had net sales of $191.5 million, up 5%.
  • Drivers and one-offs: Higher volumes, positive price in all segments and productivity gains lifted results. Cost increases were not fully recovered at historical margin rates, which pressured gross margin. Refunds of tariffs struck down by the Supreme Court added $0.02 to third-quarter EPS and $0.10 to nine-month EPS.
  • Cash and capital return: Nine-month cash from operations was $543.2 million versus $470.9 million a year earlier. Free cash flow (operating cash flow minus capital spending) was $477.3 million versus $427.0 million. In the quarter the company spent $74.6 million on share repurchases and $54.0 million on dividends.

What management is watching

  • Tariffs: After the February 20, 2026 Supreme Court decision, the administration put new tariffs in place under other legal authority and may add more. The company says tariffs enacted in 2025 and the first quarter of 2026 did not have a material impact.
  • Growth markets and restructuring: Management points to data centers, semiconductor, and space and defense as targeted markets, with broader industrial strength in FMT and FSDP. Restructuring expenses and asset impairments were $3.4 million in the quarter, including severance tied to the anticipated closure of an HST facility.
  • Capital use: Capital expenditures were $65.9 million for nine months versus $43.9 million a year earlier. The company had $699.7 million of repurchase authorization left at September 30, 2026, and repurchased 0.1 million shares for $20.5 million after quarter end. Inventories rose to support planned production.
  • Measures cited: Management directs investors to organic sales, segment Adjusted EBITDA and margin, adjusted diluted EPS ($2.33 for the quarter), free cash flow and operating working capital. The filing gives no full-year forecast.

Follow IEX in Kortex

The Kortex app shows IEX's price, options chain and IV rank, and answers your questions from live market data and SEC filings.

Free to download.

Learn the strategies

More stock briefs

For education only, not financial advice. Options involve risk and are not suitable for every investor.